Silver Book

Silver Book Fact

Patients with vertebral fractures who underwent kyphoplasty, a procedure that stabilizes fractures of the spine, were found in one study to have reduced pain, fewer new fractures, and less healthcare utilization for at least 12 months.

Grafe, Ingo A., Katharina Da Fronseca, Jochen Hillmeier, Peter-Jürgen Meeder, Martin Libicher, Gerd Nöldge, Hubert Bardenheuer, Walter Pyerin, Linus Basler, Christel Weiss, Rod S. Taylor, Peter Nawroth, and Christian Kasperk. Reduction of Pain and Fracture Incidence After Kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis. Osteoporos Int. 2005; 16(12): 2005-12. http://www.springerlink.com/content/q235u1m804u08551/?p=34936217d13e479297297d5ff7202c45&pi=72

Reference

Title
Reduction of Pain and Fracture Incidence After Kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis
Publication
Osteoporos Int
Publication Date
2005
Authors
Grafe, Ingo A., Katharina Da Fronseca, Jochen Hillmeier, Peter-Jürgen Meeder, Martin Libicher, Gerd Nöldge, Hubert Bardenheuer, Walter Pyerin, Linus Basler, Christel Weiss, Rod S. Taylor, Peter Nawroth, and Christian Kasperk
Volume & Issue
Volume 16, Issue 12
Pages
2005-12
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Researchers are looking at the use of micro-computed tomography and magnetic resonance imaging to better understand the relationship between bone structure and fracture risk. Other tools are being evaluated for…  
  • Treatment with bisphosphonates are highly cost-effective in women over the age of 70 with osteoporosis and a previous fracture.  
  • Preventing Secondary Osteoporotic Fractures Yields Big Medicare Savings
     
  • Alendronate, a bisphosphonate, has been shown to increase vertebral bone mineral density (BMD) by as much as 8% over 3-years in postmenopausal women with osteoporosis.  
  • A study of a number of osteoporosis treatments found cost-effectiveness ratios as low as $55,000 per QALY.